SEC Filing Summary: AspenBio Pharma, Inc.
Business Context and Reporting Period
This Form 8-K was filed by AspenBio Pharma, Inc. on February 21, 2012. The registrant is incorporated in Colorado and maintains its principal executive offices in Castle Rock, CO. The filing serves as a current report pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934.
Note: The request metadata referenced "Riot Platforms, Inc.", but the provided filing text explicitly identifies the registrant as "AspenBio Pharma, Inc."
Financial Metrics
The filing text does not provide specific values for revenue, profit, cash flow, margins, debt, or liquidity. This document is a procedural filing to disclose a corporate presentation rather than a financial results report.
Material Changes
No material financial changes or operational updates are detailed within the text of this Form 8-K. The filing solely references the availability of a corporate presentation.
Guidance, Outlook, and Disclosures
- Regulation FD Disclosure (Item 7.01): The company incorporated by reference a PowerPoint presentation titled "Corporate Presentation" dated February 2012 (Exhibit 99.1).
- Availability: The presentation is available on the Company's website.
- Management Commentary: No specific commentary, guidance, or risk factors are included in the body of this filing; such details are contained within the referenced Exhibit 99.1.
Key Facts for Investor Verification
- Verify the content of the "Corporate Presentation" (Exhibit 99.1) for actual business updates, as the 8-K text only references it.
- Confirm the registrant name is AspenBio Pharma, Inc., not Riot Platforms, Inc.
- Check the company website for the February 2012 presentation to access any strategic outlook or operational data.